RE:RE:RE:RE:RE:RE:RE:Presentation to the 74th Annual Meeting of the CUAA bit of the structures (Excellence centers, etc ...) that HempDoc refered to. There are networks that exist to bring faster new treatments to bedside, for the benefit of the patients.
Taken from the PMH website:
World-Leading Clinical Trials Program
Our Phase I clinical trials program is the largest in Canada and one of the top-rated programs of its kind worldwide. It is the only Phase I program in Canada to receive a grant from the U.S. National Cancer Institute (NCI).
We have leveraged our clinical trials expertise to form and lead The Princess Margaret Phase II Consortium, which is a network of 12 cancer centres across Canada and the U.S. This is the only site outside of the U.S. to secure a contract with the U.S. NCI.
Recognized Global Centre of Excellence
We are proud that Princess Margaret Cancer Centre is the only Canadian cancer institution among six global cancer centres selected by GlaxoSmithKline as a preferred centre of excellence to expedite translation of scientific knowledge into laboratory research and clinical trials.
Leaders in Participation for Clinical Trials
Our clinical trials program is the largest in Canada and one of the largest in the world, with over 700 active trials, and 1 in 6 new patients enrolled onto a clinical trial.
Our cancer centre is the only non-U.S. site chosen to be part of the Cancer Immunotherapy Trials Network funded by the U.S. NCI.